Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
MODIFIED LIQUID GELATINE, SODIUM CHLORIDE, MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM LACTATE SOLUTION
Fresenius Kabi Limited
B05AA
MODIFIED LIQUID GELATINE, SODIUM CHLORIDE, MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM LACTATE SOLUTION
3 Grams
Solution for Infusion
Product subject to prescription which may not be renewed (A)
Blood substitutes and plasma protein fractions
Authorised
2007-04-20
WHAT IS IN THIS LEAFLET 1. What GELOPLASMA, solution for infusion, is and what it is used for 2. What you need to know before you use GELOPLASMA, solution for infusion 3. How to use GELOPLASMA, solution for infusion 4. Possible side effects 5. How to store GELOPLASMA, solution for infusion 6. Contents of the pack and other information 1. WHAT GELOPLASMA, SOLUTION FOR INFUSION, IS AND WHAT IT IS USED FOR GELOPLASMA is a solution for intravenous infusion. It contains gelatin, which belongs to a group of medicines known as plasma volume expanders. Plasma volume expanders work by increasing the fluid in your blood stream, which helps keep your blood stream and therefore your blood pressure stable. This medicine is an emergency treatment in case of low blood volume in the following situations: • Haemorrhage _(bleeding),_ dehydration, capillary leak _(increased _ _microvascular _ _permeability),_ burns; • severe vasodilatation _(widening of blood vessels)_ from traumatic, surgical, septic or toxic origin. It is also used in the treatment of low blood volume associated with hypotension _(low blood_ _pressure)_ in the context of severe vasodilatation related to the effects of hypotensive drugs, notably during anesthesia. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE GELOPLASMA,SOLUTION FOR INFUSION DO NOT USE GELOPLASMA, SOLUTION FOR INFUSION: • if you are allergic to gelatin or any of the other ingredients of this medicine (listed in sec- tion 6); • if you are allergic to an allergen called “galactose-α-1,3-galactose (alpha-Gal)” or to red meat (mammal meat) and offal; • if you have an excess of fluid in the body; • if you have hyperkalaemia _(excess of potassium in the blood)_; • if you have an high accumulation of alkaline substance (e.g. bicarbonate, lactate) in your blood and body fluid; • if you are at the end of pregnancy (during labour/delivery): see "Pregnancy, breast- feeding and fertility" section. WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before using GELOPLASMA, solutio Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Geloplasma, Solution for Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION * partially hydrolysed and succinylated For the full list of excipients, see section 6.1. Ionic formula Sodium = 150 mmol/l Potassium = 5 mmol/l Magnesium = 1.5 mmol/l Chloride = 100 mmol/l Lactate = 30 mmol/l Total osmolality: 295 mOsm/kg pH: 5.8 to 7.0 3 PHARMACEUTICAL FORM Solution for infusion. Clear and colourless to slightly yellowish solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Emergency treatment of states of shock: - hypovolaemic shock resulting from : haemorrhage, dehydration, capillary leak, burns; - vasoplegic shock of traumatic, surgical, septic or toxic origin. Treatment of relative hypovolaemia associated with hypotension in the context of vasoplegia related to the effects of hypotensive drugs, notably during anesthesia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Dosage volume and rate of administration depend upon the individual patient status, circumstances and response to vascular replacement. Modified liquid gelatin is given by IV infusion (drip infusion). The infusion rate can be increased using a pump. Modified liquid gelatin* amount expressed as anhydrous gelatin …………………………………….... 3.0000 g Sodium chloride ……………………………………………………………… 0.5382 g Magnesium chloride hexahydrated …………………………………………... 0.0305 g Potassium chloride …………………………………………………………… 0.0373 g Sodium (S)-lactate solution amount expressed as sodium lactate …………………………………………. 0.3360 g per 100 ml of solution for infusion H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _ Read the complete document